Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2020 17:00 ET | Source: Arch Therapeutics, Inc.

Arch Raises $1.4 Million with Convertible Note Issuance and Warrant Reprice

FRAMINGHAM, Mass., June 05, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel wound care and biosurgical devices, announces that it has...
June 03, 2020 09:20 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics to Provide Corporate Update at the Virtual Summer Summit

FRAMINGHAM, Mass., June 03, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel wound care and biosurgical devices, will be featured as a...
April 13, 2020 08:15 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Receives CE Mark Approval for AC5™ Topical Hemostat in Europe

FRAMINGHAM, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today...
March 23, 2020 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Receives Marketing Clearance from the US FDA Related to the AC5® Topical Gel Supply Chain

FRAMINGHAM, Mass., March 23, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
March 04, 2020 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Novel Self-Assembling Agent for Use in Endoscopic Procedures to be Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting on April 2, 2020

FRAMINGHAM, Mass., March 04, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
March 02, 2020 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics to Provide Corporate Update at the 2020 LD Micro Virtual Investor Conference

FRAMINGHAM, Mass., March 02, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
January 08, 2020 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics to Provide Corporate Update at Biotech Showcase™ 2020 on January 13th, 2020

FRAMINGHAM, Mass., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
October 17, 2019 08:00 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Announces $2.5 Million Registered Direct Offering

FRAMINGHAM, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
October 07, 2019 15:59 ET | Source: Arch Therapeutics, Inc.

UPDATE - Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY

FRAMINGHAM, Mass., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
October 07, 2019 11:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY

FRAMINGHAM, Mass., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right